#USA #Plano #Bimini Health Tech #Puregraft #Dermapose

Bimini Health Tech Achieves EU MDR Certification

Bimini Health Tech, a prominent global player in women's health medical technologies, recently announced a significant milestone: the company has attained the EU Medical Device Regulation (MDR) certification for its product lines. This development marks a vital step in the company's ongoing global expansion efforts.

Enhanced Product Offerings

With the new MDR certification, Bimini is now able to broaden the availability of its Puregraft® and Dermapose® fat transfer products throughout Europe. In a statement, Brad Conlan, CEO of Bimini Health Tech, expressed his enthusiasm, stating, "We are very pleased to obtain the EU MDR certification for Bimini and to expand our product approvals for our two fat transfer product lines, Puregraft and Dermapose. This achievement reflects the tireless dedication of our team and our ongoing investment in providing innovative high-quality technologies to patients and physicians worldwide."

The Growing Market for Fat Transfer Procedures

According to recent statistics from the International Society of Aesthetic Plastic Surgery (ISAPS), fat transfer surgeries have surged by 19.2% year-on-year, now exceeding 940,000 procedures globally. Bimini Health Tech aims to capture a significant portion of this expanding market with its Puregraft and Dermapose offerings in the short term.

Innovative Product Lines

Puregraft® Technology

The Puregraft® system is designed for the efficient and rapid filtration and purification of large volumes of fat in a closed system. It employs patented dialysis filtration technology to delicately separate viable adipose tissue from blood, oil, and waste, resulting in a high concentration of healthy, viable fat cells. The Puregraft® product line includes Puregraft 50, Puregraft 250, Puregraft 850, and the recent FDA-approved Puregraft SYNC®. These products are currently marketed in over 50 countries worldwide.

You can discover more about the Puregraft® product line and the new Puregraft SYNC® technology on their official website.

Dermapose® Technology

Dermapose® is another innovative solution aimed at the extraction, purification, resizing, and injection of micro-fat in a single closed system. This technology not only provides efficient adipose treatment and re-injection but also streamlines the workflow, enhancing versatility and consistency across procedures. Following the EU MDR certification, Dermapose® is available in the United States, European Union, Japan, Brazil, Australia, Canada, and Saudi Arabia. Learn more about Dermapose® technology on Bimini’s website.

About Bimini Health Tech

Founded in 2013, Bimini Health Tech has established itself as a leading name in women’s health market. With decades of industry experience, Bimini focuses on developing, acquiring, and marketing innovative products that offer high-end solutions to patients and healthcare professionals. Their portfolio includes the Puregraft fat filtration systems, the acellular dermal matrix Essence, and Dermapose fat harvesting and calibration systems.

Backed by over 100 patents and more than 25 scientific publications, Bimini products have been employed in over 1.5 million procedures across the globe, underscoring their commitment to quality and innovation.

For further information on Bimini Health Tech and their product range, visit www.biminihealthtech.com.